Who Owns THERAVANCE BIOPHARMA INC (TBPH)? -- Institutional Holders (2026-06-30)

202 institutions reported holding $823.9M of THERAVANCE BIOPHARMA INC (TBPH) in SEC 13F filings for 2026-06-30. Largest institutional holders: Madison Avenue Partners, LP ($156.6M), Weiss Asset Management LP ($126.8M), BlackRock, Inc. ($77.6M), Newtyn Management, LLC ($58.4M), Irenic Capital Management LP ($46.9M). Source: SEC Form 13F.

RankInstitutionValueSharesChange
1Madison Avenue Partners, LP$156.6M9.2MTrimmed
2Weiss Asset Management LP$126.8M7.5MHold
3BlackRock, Inc.$77.6M4.6MAdded
4Newtyn Management, LLC$58.4M3.4MTrimmed
5Irenic Capital Management LP$46.9M2.8MHold
6VANGUARD GROUP INC$42.3M2.5MTrimmed
7STATE STREET CORP$22.6M1.3MAdded
8TWO SIGMA INVESTMENTS, LP$20.8M1.2MTrimmed
9D. E. Shaw & Co., Inc.$20.2M1.2MAdded
10ACADIAN ASSET MANAGEMENT LLC$20.0M1.2MTrimmed
11GEODE CAPITAL MANAGEMENT, LLC$19.0M1.1MTrimmed
12DIMENSIONAL FUND ADVISORS LP$17.7M1.0MAdded
13MACKENZIE FINANCIAL CORP$16.8M985,848Added
14MORGAN STANLEY$12.0M705,202Added
15Oasis Management Co Ltd.$9.9M583,490Hold
16CITADEL ADVISORS LLC$9.1M537,468Added
17UBS Group AG$8.3M488,309Trimmed
18Qube Research & Technologies Ltd$7.3M429,813Added
19NORTHERN TRUST CORP$6.9M404,356Added
20Jupiter Topco LLC$6.6M387,493New
21GOLDMAN SACHS GROUP INC$5.8M339,960Trimmed
22CHARLES SCHWAB INVESTMENT MANAGEMENT INC$5.5M321,154Added
23Sixth Street Partners Management Company, L.P.$5.5M321,154New
24GLAZER CAPITAL, LLC$5.1M301,834New
25JPMORGAN CHASE & CO$3.8M221,846Added

Source: SEC Form 13F filings · as of 2026-06-30